Two decades of progress in gastric cancer peritoneal metastasis: a bibliometric perspective on molecular mechanisms and therapeutic innovations.

Journal: Frontiers in oncology
Published Date: May 30, 2025

Abstract

BACKGROUND: Gastric cancer (GC) is the fifth most common malignant tumor worldwide. The peritoneum is a common site of metastasis in advanced GC, and patients with gastric cancer peritoneal metastasis (GCPM) have a very low 5-year survival rate. Systemic therapy has limited efficacy for peritoneal metastases, and early diagnosis is difficult. In this paper, we analyzed the GCPM-related literature by bibliometric methods, aiming to identify the research hotspots and trends and to provide a basis for clinical practice and research planning.

Authors

  • Jin Qian
    School of Software, Shandong University, Jinan, China.
  • Xiaoxuan Tu
    Department of Oncology, Zhejiang Hospital, Hangzhou, China.
  • Jianglin Chen
    Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, China.
  • Sisi Chen
    Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, China.
  • Yi Zhou
    Eye Center of Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Chuan Sun
    Research Institute of Natural Gas Technology, Petro China Southwest Oil and Gas Field Company, Chengdu, 610213, China.
  • Zhibing Wu
    Zhejiang Provincial Key Lab of Geriatrics, Department of Geriatrics, Zhejiang Hospital, Hangzhou, China.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals